TY - JOUR
T1 - Hollow mesoporous organosilica nanoparticles
T2 - A generic intelligent framework-hybridization approach for biomedicine
AU - Chen, Yu
AU - Meng, Qingshuo
AU - Wu, Meiying
AU - Wang, Shige
AU - Xu, Pengfei
AU - Chen, Hangrong
AU - Li, Yaping
AU - Zhang, Lingxia
AU - Wang, Lianzhou
AU - Shi, Jianlin
N1 - Publisher Copyright:
© 2014 American Chemical Society.
PY - 2014/11/19
Y1 - 2014/11/19
N2 - Chemical construction of molecularly organic-inorganic hybrid hollow mesoporous organosilica nanoparticles (HMONs) with silsesquioxane framework is expected to substantially improve their therapeutic performance and enhance the biological effects beneficial for biomedicine. In this work, we report on a simple, controllable, and versatile chemical homology principle to synthesize multiple-hybridized HMONs with varied functional organic groups homogeneously incorporated into the framework (up to quintuple hybridizations). As a paradigm, the hybridization of physiologically active thioether groups with triple distinctive disulfide bonds can endow HMONs with unique intrinsic reducing/acidic- and external high intensity focused ultrasound (HIFU)-responsive drug-releasing performances, improved biological effects (e.g., lowered hemolytic effect and improved histocompatibility), and enhanced ultrasonography behavior. The doxorubicin-loaded HMONs with concurrent thioether and phenylene hybridization exhibit drastically enhanced therapeutic efficiency against cancer growth and metastasis, as demonstrated both in vitro and in vivo.
AB - Chemical construction of molecularly organic-inorganic hybrid hollow mesoporous organosilica nanoparticles (HMONs) with silsesquioxane framework is expected to substantially improve their therapeutic performance and enhance the biological effects beneficial for biomedicine. In this work, we report on a simple, controllable, and versatile chemical homology principle to synthesize multiple-hybridized HMONs with varied functional organic groups homogeneously incorporated into the framework (up to quintuple hybridizations). As a paradigm, the hybridization of physiologically active thioether groups with triple distinctive disulfide bonds can endow HMONs with unique intrinsic reducing/acidic- and external high intensity focused ultrasound (HIFU)-responsive drug-releasing performances, improved biological effects (e.g., lowered hemolytic effect and improved histocompatibility), and enhanced ultrasonography behavior. The doxorubicin-loaded HMONs with concurrent thioether and phenylene hybridization exhibit drastically enhanced therapeutic efficiency against cancer growth and metastasis, as demonstrated both in vitro and in vivo.
UR - https://www.scopus.com/pages/publications/84912553488
U2 - 10.1021/ja508721y
DO - 10.1021/ja508721y
M3 - 文章
C2 - 25343459
AN - SCOPUS:84912553488
SN - 0002-7863
VL - 136
SP - 16326
EP - 16334
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 46
ER -